VT substrate mapping — locating scar-related reentry channels for catheter ablation
Most sustained monomorphic ventricular tachycardia in structural heart disease is not a disorder of a single irritable cell — it is a geometry problem. Myocardial infarction, non-ischemic cardiomyopathy, or prior cardiac surgery leaves behind a scar of dead, electrically silent collagen. But scars are rarely uniform: thin bundles of surviving myocardial fibers frequently survive within and around the fibrotic mass, conducting slowly and anisotropically. These surviving channels — sometimes only a millimeter or two wide — are the anatomical substrate that allows a single premature beat to loop endlessly around the scar as ventricular tachycardia.
A healed myocardial infarct is not a homogeneous scar — it is a three-dimensional patchwork:
• Dense scar core: replacement fibrosis, no viable myocytes, electrically silent • Border zone / patchy fibrosis: surviving myocyte bundles interleaved with collagen septae, conducting slowly because current has to zig-zag around fibrotic barriers • Surviving channels: narrow corridors of viable, coupled myocardium running through or around the densest scar, often connecting two areas of normal tissue
For reentry to occur, three conditions from classical circuit theory must be satisfied: an area of unidirectional conduction block (the dense scar core, which simply cannot conduct), a pathway of slow conduction (the surviving channel, whose conduction velocity may drop below 0.2 m/s due to fibrotic uncoupling), and a wavefront that arrives back at its origin after the tissue ahead has recovered excitability. The channel’s slow conduction is what buys time for the rest of the circuit to repolarize and become excitable again — without that delay, the wavefront would simply collide with refractory tissue and extinguish.
A single scar frequently supports more than one possible reentry circuit and more than one 12-lead VT morphology, because a channel can be entered or exited from either end, and multiple channels may coexist within one infarct — this is why substrate-based strategies aim to eliminate every plausible pathway, not just the one VT that happened to be induced.
Supraventricular tachycardias and many idiopathic ventricular arrhythmias arise from a discrete focus or a small, well-defined circuit (e.g., AV nodal reentry) in structurally normal hearts, and can usually be mapped and terminated by targeting one point of earliest activation or one accessory pathway.
Scar-related VT is different in scale and structure: the circuit can be several centimeters long, wind through three-dimensional scar (including the mid-myocardium or epicardium), and the substrate itself — not just a single vulnerable cell — is the disease. This is why the diagnostic and therapeutic approach pivots from "find the earliest point" to "map and characterize the whole scar," and why substrate mapping in sinus rhythm, rather than activation mapping during tachycardia, has become the dominant strategy for these patients.
Activation mapping — tracing a wavefront point-by-point during an ongoing arrhythmia — works well when the rhythm is stable and well tolerated. Scar-related VT frequently is neither: rates can exceed 200 bpm, cardiac output collapses, and many patients decompensate within seconds of induction. Electrophysiologists therefore build most of the diagnostic map during sinus rhythm, when the patient is hemodynamically stable, and infer the likely circuit from voltage and timing characteristics of the tissue rather than watching the tachycardia unfold in real time.
Inducing VT to map it directly is powerful when tolerated, but comes with real costs: repeated inductions and cardioversions are hard on an already-diseased heart, general anesthesia further destabilizes tenuous hemodynamics, and each induction/termination cycle adds procedural time and risk without guaranteeing the map will complete before the patient needs to be shocked back to sinus rhythm.
Substrate mapping sidesteps this by exploiting a key insight: the anatomic channels capable of supporting VT leave a signature in sinus rhythm. Areas of scar conduct abnormally at baseline too — slowly, with fractionated or delayed electrograms — whether or not tachycardia is currently running through them. A sufficiently dense, high-resolution voltage and timing map acquired in sinus rhythm can identify essentially the same channels that a much riskier activation map during VT would reveal.
A multipolar or basket catheter (often supplemented by a roving ablation catheter) is dragged systematically across the endocardial — and, when needed, epicardial — surface of the ventricle while the patient remains in stable sinus rhythm (or paced rhythm). At each contact point the system simultaneously records:
• Local activation time relative to a fixed reference (e.g., surface ECG QRS onset) • Bipolar and unipolar electrogram voltage amplitude • Electrogram morphology — duration, fractionation, presence of late/delayed components
High-density multi-electrode catheters can acquire thousands of points in the time it once took to gather a few hundred, while respiratory and cardiac motion is compensated in real time so the resulting 3D geometry stays accurate to within roughly a millimeter. The result is a color-coded electroanatomic map of the entire chamber built without ever needing the heart to be in a dangerous rhythm.
Once thousands of points have been collected in sinus rhythm, the single most informative measurement at each site is the amplitude of the local bipolar electrogram. Healthy, well-coupled myocardium generates large, sharp signals; scarred, fibrotic tissue generates small or absent ones. Applying consistent voltage thresholds converts a cloud of raw electrical measurements into a color map that clearly separates dense scar, the critical border zone, and normal muscle.
Bipolar electrograms (recorded between two closely spaced electrodes) are highly local and far-field-resistant, making the classic <0.5 mV / 0.5–1.5 mV / >1.5 mV scheme reliable for endocardial surface scar. But bipolar recordings are relatively insensitive to scar that lies deeper in the wall or on the opposite (e.g., epicardial) surface from the mapping catheter.
Unipolar electrograms (recorded against a distant reference) have a larger field of view and can reveal transmural or epicardial scar even when the endocardial bipolar voltage looks deceptively normal — a mismatch that itself is diagnostically useful, since it flags scar hidden beneath apparently healthy-looking endocardium.
The dense scar core is, almost by definition, electrically silent and cannot itself sustain conduction — it is the obstacle the circuit wraps around, not the pathway. The border zone is where the action is: intermediate voltage here reflects a mixture of viable myocyte bundles and fibrotic septae, exactly the substrate capable of the slow, decremental conduction that a reentrant circuit needs. Extensive, high-density border-zone mapping is what allows the operator to trace the surviving channels that run through it and to prioritize which regions deserve the most scrutiny with pacing maneuvers.
Voltage thresholds are a validated but imperfect proxy — catheter contact force, electrode spacing, and wavefront direction all shift the numbers. Experienced operators corroborate voltage-defined channels with electrogram morphology and pacing response before committing to an ablation target.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Dense scar core | |||
| Border zone | |||
| Healthy myocardium | |||
| Unipolar-only scar |
A border zone can be broad, and not every low-voltage corridor within it is functionally important. The isthmus — the narrowest, most protected segment of the reentry circuit — is the highest-value ablation target, because a lesion placed there can interrupt every wavefront regardless of which end of the circuit it entered from. Operators combine several complementary techniques, all still largely performed in or near sinus rhythm, to narrow dozens of candidate channels down to the one or few that truly matter.
While probing the border zone, several electrogram features single out sites likely to sit within a functional channel:
• Late potentials (LPs): low-amplitude deflections occurring after the end of the surface QRS, reflecting delayed activation of surviving fibers • Local abnormal ventricular activities (LAVA): fractionated, multi-component signals distinct from the far-field ventricular electrogram, indicating diseased but still-conducting tissue • Isolated diastolic potentials (IDPs): discrete signals occurring in the diastolic interval, most specific when recorded during induced, hemodynamically tolerated VT
These signatures do not require VT to be present — LPs and LAVA are recordable in sinus rhythm and are one of the main reasons substrate mapping without induction can still localize a highly specific ablation target.
Pace-mapping exploits the fact that pacing from a point inside the true exit of the reentry circuit reproduces a paced QRS morphology nearly identical to the clinical VT QRS on all 12 surface leads, because the wavefront exits and activates the ventricles the same way. The operator paces sequentially at multiple border-zone sites and compares each resulting QRS to a stored template of the clinical VT — a high percentage match (commonly reported as ≥ 10 or 11 of 12 leads concordant) nominates that site as being at or near the circuit exit.
When VT can be safely induced for brief periods, entrainment mapping adds further confirmation: pacing slightly faster than the tachycardia from a candidate site and checking whether the post-pacing interval (PPI) at that site closely matches the tachycardia cycle length (TCL), and whether the paced QRS shows concealed fusion with the clinical VT — both indicate the pacing site lies within the protected isthmus itself, not merely nearby.
The defining feature of substrate-based VT ablation is that a durable result can be achieved even when the clinical VT is never induced or is too unstable to map in real time. Once channels or a probable isthmus have been localized through voltage mapping and pacing maneuvers, radiofrequency lesions are placed to electrically transect them — either narrowly, targeting only identified channels, or more broadly through scar homogenization, aiming to eliminate every plausible reentry pathway the scar could support.
Channel-targeted ablation: once pace-mapping and electrogram analysis have converged on one or a small number of specific channels, focused linear lesions are placed to transect each one — typically drawn from the deepest part of the dense scar out to the nearest border with healthy tissue, ensuring the entire cross-section of the corridor is electrically severed rather than just a single point along it.
Scar homogenization: rather than betting on a small number of channels, the operator ablates the entire low-voltage border zone in a systematic grid or linear lesion set, deliberately eliminating every corridor of surviving tissue that could theoretically support a circuit — including ones never explicitly identified or pace-mapped. This trades a longer procedure and more extensive myocardial injury for a lower chance of leaving an unrecognized channel behind.
Both strategies share the same underlying logic: because scar-related VT circuits can be multiple and only one may have been induced (or none at all), an ablation plan built purely on eliminating what was actually seen during tachycardia is fragile — substrate-based approaches instead aim to make the entire scar incapable of sustaining reentry.
After lesion delivery, operators typically re-check the ablated corridor for loss of local capture and abolition of any late potentials or LAVA signals that were present before ablation — a favorable sign that the tissue is now electrically silent rather than merely stunned. Programmed ventricular stimulation is then usually repeated at the end of the case: non-inducibility of any sustained monomorphic VT is used as the best available acute surrogate for procedural success, even though it does not guarantee that every microscopic channel has been eliminated.
Long-term outcomes depend heavily on how extensive and how complete the underlying substrate mapping was: incomplete mapping of the border zone, or stopping after only one or two channels are ablated when others remain unaddressed, is a recognized driver of VT recurrence during follow-up.